The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Urispas 200 mg Film-coated Tablets

Recordati Ireland LimitedPA1404/001/001

Main Information

Trade NameUrispas 200 mg Film-coated Tablets
Active SubstancesFlavoxate hydrochloride
Dosage FormFilm-coated tablet
Licence HolderRecordati Ireland Limited
Licence NumberPA1404/001/001

Group Information

ATC CodeG04BD Drugs for urinary frequency and incontinence
G04BD02 flavoxate


License statusAuthorised
Licence Issued15/10/1990
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back